Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more) Digital Health Meets AI -CSE: ALEN.U (click to learn more) New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News MultiCell Technologies Inc (EM) MCET

Healthcare Biotechnology
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a... see more

Recent & Breaking News (EXPM:MCET)

    MultiCell Immunotherapeutics And Oxis Biotech Sign Antibody-Drug Conjugate R&D, Product License And Commercialization Agreement

    PR Newswire March 12, 2015

    MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application

    PR Newswire December 10, 2014

    MultiCell Technologies Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer

    PR Newswire August 25, 2014

    MultiCell Technologies Files U.S. and International Patent Applications for the Treatment of Liver Cancer

    PR Newswire March 20, 2014

    MultiCell Technologies Seeks Patent for Cancer-Fighting Technology

    ACCESS Newswire March 4, 2014

    MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics

    PR Newswire January 15, 2014

    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of MCT-485, a Noncoding miRNA for Cancer Treatment

    PR Newswire November 13, 2013

    MultiCell Technologies Expands Scope of Research Agreement for the Treatment of Liver Cancer

    PR Newswire October 2, 2013

    MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer

    PR Newswire August 6, 2013

    MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer

    PR Newswire May 16, 2013

    MultiCell Technologies and Federal National Mortgage Association Review: (OTCQB: MCET), (OTCQB: FNMA)

    ACCESS Newswire March 3, 2013

    Squawk Box Stocks Reports on: Swingplane Ventures, Inc. (OTCQB: SWVI), MultiCell Technologies, Inc. (OTCQB: MCET), China Teletech Holding, Inc. (OTCQB: CNCT), Advaxis, Inc. (OTCQB: ADXS).

    Marketwired February 25, 2013

    MultiCell Technologies Delivered Presentation at 2012 ASCB Meeting

    PR Newswire December 26, 2012

      Podcasts